Esperion Therapeutics, Inc.
ESPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $145 | $82 | $125 | $209 |
| Short-Term Investments | $0 | $0 | $42 | $50 |
| Receivables | $80 | $48 | $34 | $23 |
| Inventory | $94 | $66 | $35 | $34 |
| Other Curr. Assets | $18 | $5 | $10 | $11 |
| Total Curr. Assets | $338 | $201 | $247 | $329 |
| Property Plant & Equip (Net) | $6 | $5 | $1 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $50 |
| Total NC Assets | $6 | $5 | $1 | $53 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $344 | $206 | $248 | $382 |
| Liabilities | – | – | – | – |
| Payables | $52 | $32 | $23 | $18 |
| Short-Term Debt | $102 | $35 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $9 | $25 | $4 | $6 |
| Other Curr. Liab. | $13 | $49 | $9 | $9 |
| Total Curr. Liab. | $246 | $156 | $92 | $73 |
| LT Debt | $484 | $502 | $260 | $258 |
| Deferred Rev, NC | $0 | $0 | $0 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $219 | $246 |
| Total NC Liab. | $486 | $505 | $479 | $505 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $5 | $1 | $2 |
| Total Liabilities | $733 | $661 | $572 | $579 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,601 | -$1,549 | -$1,340 | -$1,106 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$389 | -$455 | -$324 | -$197 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $344 | $206 | $248 | $382 |
| Net Debt | $441 | $454 | $135 | $49 |